Caxton Associates (New York)’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,170
| Closed | -$536K | – | 589 |
|
|
2023
Q1 | $536K | Buy |
+5,170
| New | +$536K | 0.08% | 242 |
|
|
2022
Q2 | – | Sell |
-1,396
| Closed | -$238K | – | 647 |
|
|
2022
Q1 | $238K | Buy |
1,396
+157
| +13% | +$26.8K | 0.02% | 379 |
|
|
2021
Q4 | $259K | Buy |
1,239
+78
| +7% | +$16.3K | 0.03% | 425 |
|
|
2021
Q3 | $224K | Sell |
1,161
-1,698
| -59% | -$328K | 0.02% | 355 |
|
|
2021
Q2 | $809K | Buy |
2,859
+585
| +26% | +$166K | 0.09% | 79 |
|
|
2021
Q1 | $482K | Buy |
+2,274
| New | +$482K | 0.04% | 147 |
|
|
2020
Q4 | – | Sell |
-2,388
| Closed | -$393K | – | 228 |
|
|
2020
Q3 | $393K | Buy |
+2,388
| New | +$393K | 0.04% | 134 |
|
|
2018
Q3 | – | Sell |
-2,104
| Closed | -$337K | – | 447 |
|
|
2018
Q2 | $337K | Buy |
+2,104
| New | +$337K | 0.02% | 261 |
|
|
2017
Q2 | – | Sell |
-10,637
| Closed | -$472K | – | 473 |
|
|
2017
Q1 | $472K | Buy |
+10,637
| New | +$472K | ﹤0.01% | 211 |
|